AbbVie | Der Umsatz



Sales Veränderung Datum
AbbVie USD 15.1B 642M 2024-12
Abbott USD 10.97B 370M 2024-12
ALKERMES USD 430M 51.9M 2024-12
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
J&J USD 22.52B 49M 2024-12
Medtronic USD 8.29B 111M 2025-01
Merck USD 15.62B 1.03B 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
UCB EUR 3.36B 572M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Zoetis USD 2.32B 71M 2024-12



AbbVie Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.